Giannakaki Aikaterini-Gavriela, Stylianaki Aikaterini, Giannakaki Maria-Nektaria, Koura Sophia, Papachatzopoulou Eutychia, Papapanagiotou Ioannis, Baroutis Dimitris, Rompoti Dionysia, Marinopoulos Spyros, Bikouvaraki Eleni-Sivylla, Karathanasis Dimitriοs, Pappas Dimitriοs, Pappa Kalliopi, Daskalakis Georgios, Dimitrakakis Constantine
First Department of Obstetrics and Gynecology, Alexandra University Hospital, National and Kapodistrian University of Athens, 11528, Athens, Greece.
Medical School, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.
Aesthetic Plast Surg. 2025 May 21. doi: 10.1007/s00266-025-04921-w.
BACKGROUND: Autologous fat transplantation to the breast, a minimal invasive technique, has significantly expanded in aesthetic and reconstructive surgery over the past two decades. Initially used for lumpectomy defects or correcting contour deformities post-breast reconstruction, it is now also performed as a stand-alone technique for primary breast augmentation or as a complementary method to implant-based augmentation. However, this surgical technique is associated with a high absorption rate. The use of fat grafts for breast augmentation remains controversial due to concerns about its safety, efficacy, and impact on breast cancer. METHODS: This review examines the literature on cell-assisted lipotransfer (CAL) and PRP-assisted lipotransfer, comparing fat graft survival, complication rates, and oncological safety with conventional autologous lipotransfer. RESULTS: CAL and PRP-assisted lipotransfer techniques demonstrate improved fat graft retention and reduced complications compared to conventional methods. Several studies report a potential reduction in the absorption rate of fat grafts with improvements in aesthetic outcomes. CONCLUSIONS: While CAL and PRP-assisted lipotransfer have shown promising results in enhancing fat graft survival and reducing complications, there are still concerns about their oncological safety. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
背景:自体脂肪移植到乳房是一种微创技术,在过去二十年中,其在美容和重建手术中的应用显著增加。该技术最初用于乳房肿块切除术后缺损或矫正乳房重建后的轮廓畸形,现在也作为一种独立技术用于初次隆乳或作为基于植入物隆乳的补充方法。然而,这种手术技术的吸收率很高。由于对其安全性、有效性以及对乳腺癌的影响存在担忧,使用脂肪移植进行隆乳仍然存在争议。 方法:本综述研究了关于细胞辅助脂肪移植(CAL)和富血小板血浆(PRP)辅助脂肪移植的文献,将脂肪移植存活率、并发症发生率和肿瘤学安全性与传统自体脂肪移植进行比较。 结果:与传统方法相比,CAL和PRP辅助脂肪移植技术显示出更好的脂肪移植保留率和更低的并发症发生率。几项研究报告称,随着美学效果的改善,脂肪移植的吸收率可能会降低。 结论:虽然CAL和PRP辅助脂肪移植在提高脂肪移植存活率和减少并发症方面显示出了有前景的结果,但对其肿瘤学安全性仍存在担忧。 未指定证据水平:本刊要求作者为每篇适用循证医学排名的投稿指定证据水平。这排除了综述文章、书评以及涉及基础科学、动物研究、尸体研究和实验研究的稿件。有关这些循证医学评级的完整描述,请参考目录或作者在线指南www.springer.com/00266 。
Aesthetic Plast Surg. 2025-5-21
Aesthetic Plast Surg. 2016-4
Aesthetic Plast Surg. 2024-2
Aesthetic Plast Surg. 2020-2
Int J Mol Sci. 2024-12-4
Transl Breast Cancer Res. 2024-4-29
Biomedicines. 2023-12-19
Medicina (Kaunas). 2022-9-6